Facing the cancer telomerase issue from a different perspective, a couple of groups used Cas9 to edit the promoter sequences of TERT, providing a useful tool for studying telomerase biology and understanding the molecular basis by which cancer-associated TERT mutations impact telomerase activity [48,49]. Here, TERT is linked to cancer.